The power of gut enzymes: why healthy eating affects everyone differently
Peer-Reviewed Publication
This month, we’re focusing on infectious diseases, a topic that affects lives and communities around the world. Here, you’ll find the latest research news, insights, and discoveries shaping how infectious diseases are being studied, prevented, and treated globally.
Updates every hour. Last Updated: 10-Jan-2026 02:11 ET (10-Jan-2026 07:11 GMT/UTC)
Researchers from the Cluster of Excellence »Balance of the Microverse« at the University of Jena and the Leibniz-HKI, together with international partners, have uncovered a mechanism that determines how our gut microbiome processes healthful plant compounds. The »chemical cookbook« of gut bacteria varies from person to person—and is often disrupted in chronic diseases. The findings pave the way for personalized nutrition plans that specifically promote balance in the microbiome.
Columbia researchers found that iron-deficient mice with influenza were unable to produce a key immune protein in the lungs that helps fight infections, even when iron levels returned to normal.
A new Genomic Press Interview with Prof. Dr. Paul Lucassen shares insights from his research spanning 30 years in which he explores how the adult brain continues to produce new neurons, and how this process, and other plasticity-related aspects like cognition, are modulated by (early life) stress, exercise, nutrition, and inflammation, revealing unexpected connections between early childhood experiences and later vulnerability to psychiatric disorders and dementia. His work offers hope that brain plasticity can maybe one day be harnessed for therapeutic and preventive approaches.
New research shows that three-quarters of the world are not getting enough omega-3. A new study finds that 76 per cent of people worldwide are not meeting recommended intakes of EPA and DHA, revealing a significant global public health gap.
The research is the first global review of national and international omega-3 intake recommendations across all life stages for generally healthy people.
In a new paper published in Clinical Nutrition, “Sarcopenic Diabetes Is an Under-Recognized and Unmet Clinical Priority,” nutrition and diabetes experts are calling attention to a little-known but serious complication of diabetes, the progressive loss of muscle mass and strength, a condition known as sarcopenic diabetes. Moreover, authors warn that the new class of weight loss drugs, like semaglutide, complicates this condition as weight loss with these drugs is caused, in part, by a decrease in muscle mass.